Addendum: Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment
Metrics: PDF 452 views | ?
1A.M. Granov Russian Research Center for Radiology and Surgical Technologies of the Ministry of Health of the Russian Federation, Pesochny, St. Petersburg 197758, Russia
2N.N. Petrov National Medical Research Center of Oncology, Pesochny, St. Petersburg 197758, Russia
Published: February 25, 2023
Copyright: © 2023 Zharinov et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
This article has an addendum: Patient consent was required and obtained. This study was approved by the Russian Research Centre of Radiology and Surgical Technologies Ethics Committee (Approval #1041Y).
Original article: Oncotarget. 2020; 11:3723–3729. DOI: https://doi.org/10.18632/oncotarget.27757
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.